Somru Adapts Platform for COVID-19
Charlottetown-based Somru BioScience Inc. is adapting its antibody platform to assist in developing therapeutic and diagnostic solutions for COVID-19 and other infectious diseases.
The company has been developing a range of products centred around antibody technology for research, diagnostic and clinical applications. The products have been mainly used so far in research, with clients in 27 countries.